Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy crawled date : 2021 - 05 - 20 save search
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
Published: 2021-05-20 (Crawled : 22:00) - biospace.com/
BMY | $48.3 0.96% 0.21% 3.3K
|
Health Technology
|
| O: -0.35%
H: 2.92%
C: 2.57%
food treatment therapy cancer drug iot nivolumab
FDA approves nivolumab for resected esophageal or GEJ cancer
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
BMY | $48.3 0.96% 0.21% 3.3K
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
fda cancer approval fda approval nivolumab
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
PFE A | $25.39 -0.12% -0.08% 190K
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.3 0.96% 0.21% 3.3K
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.76 -4.03% -0.21% 0
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.0 -0.73% -0.94% 0
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $10.23 -5.63% -6.38% 0
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.05 -5.41% -4.72% 670
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | $893.99 -0.8% -0.84% 0
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.28 -7.25% -9.09% 1.3M
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $52.82 0.19% 0.19% 120
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $116.69 -1.35% -1.41% 1.6M
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $22.49 -1.66% -1.78% 2.1M
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | News | $88.9 0.59% 0.58% 0
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE | $131.96 0.08% 0.06% 110K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | $262.75 -0.5% -0.49% 320
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | News | $145.16 -0.11% -0.19% 1
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | News | $29.43 1.38% 1.36% 0
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Intensity Therapeutics Announces Two Abstracts to Be Presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2021-05-20 (Crawled : 13:15) - biospace.com/
BMY | $48.3 0.96% 0.21% 3.3K
|
Health Technology
|
| O: -0.35%
H: 2.92%
C: 2.57%
Bristol Myers Squibb Elects Manuel Hidalgo Medina, M.D., Ph.D. to Board of Directors
Published: 2021-05-20 (Crawled : 12:00) - biospace.com/
BMY | $48.3 0.96% 0.21% 3.3K
|
Health Technology
|
| O: -0.35%
H: 2.92%
C: 2.57%
AGEN | $4.97 -7.96% -8.65% 1.6M
|
Health Technology
|
| O: -0.6%
H: 5.9%
C: 0.6%
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.